IV Medications Elsevier vs ScrollMD
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
IV Medications Elsevier
This comprehensive IV drug handbook provides nurses and health professionals with up-to-date information on over 400 intravenous drugs. It features quick-access monographs, highlighted warnings, and life-stage dosage variances to ensure safe and accurate medication administration.
- Over 400 IV drug monographs
- New FDA-approved drug updates
- Highlighted Black Box Warnings
- Life stage dosage variances
- Alphabetical drug format
- Annual publication
Read full descriptionHide full description
"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content. For nearly 50 years - #1 IV drug handbook to safely administer more than 400 intravenous drugs! Drug monographs for 10-20 newly approved drugs by the FDA include the most current information Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2026 edition are many new monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings. New to this edition - New drug monographs for approximately 10-20 newly approved drugs by the FDA provides readers with the most current drug information - Each monograph updated as necessary with new interactions, precautions, alerts, patient teaching instructions, and other need-to-know information. Current information helps nurses feel confident in the accuracy of the information and helps prevent medication dispensing errors Key Features - Annual publication prevents users from referencing outdated information - 40-year history of impeccable accuracy reinforces the importance of safe IV drug administration - Monographs on more than 400 IV drugs offers an impressive breadth of coverage that goes well beyond any comparable drug reference - Proven, clinically-optimized page layout keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page - Highlighted Black Box Warnings and relevant content make locating critical information fast and easy - Special circumstances in blue-screened text call attention to important circumstances that may not warrant black box warnings - Convenient, alphabetical format organizes all drug monographs by generic name, allowing users to find any drug in seconds - Dilution and dosage charts within monographs provide quick access to essential clinical information - Life stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients Content licensed from printed edition ISBN-10: 0443269599 Content licensed from printed edition ISBN-13: 9780443269592 SUBSCRIPTION : Please purchase a yearly auto-renewing subscription to receive content access and available updates. Yearly auto-renewing payments- $49.99 Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable. If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000 Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx Author(s):Shelly Rainforth Collins, PharmD Publisher:Elsevier Health Sciences
ScrollMD
Read full descriptionHide full description
ScrollMD turns the latest medical research into a fast, swipeable feed. Instead of digging through databases, you scroll through clean "study cards" — one paper per screen — and absorb the essentials in seconds. Each card distills an open-access paper into: • TL;DR — the study in one line • Key Finding — the headline result, with the number that matters • Why It Matters — the clinical takeaway • Caveat — the limitation to keep in mind Tap through to the original paper (DOI) any time you want the full text. WHY SCROLLMD • Built for clinicians first — cardiology, oncology, neurology, infectious disease, endocrine, pulmonary, and a "For You" mix. • Search your own topic — type what you're working on and get the most relevant recent papers. • Reputable, open-access sources — content is indexed from PubMed / Europe PMC and reputable journals. We link to the original; we never paywall or republish copyrighted PDFs. • Save, cite, and share the studies you want to come back to. • Ask for an AI summary on any card when you want a quick plain-language recap. FOR CLINICIANS, STUDENTS, AND THE CURIOUS Whether you're a physician staying current between patients, a resident or student building your foundation, or simply someone who wants to follow real research instead of headlines, ScrollMD makes keeping up feel effortless. IMPORTANT ScrollMD provides educational summaries of published research. It is not a medical device and does not provide medical advice, diagnosis, or treatment. Summaries are generated automatically and may omit nuance — always consult the original paper and use your professional judgment. Nothing in ScrollMD should be used to make clinical decisions for an individual patient. Sign in with Apple or Google to sync your saves and join the discussion, or continue as a guest.
Screenshots
Verdict
The clearest difference is in-app purchases: ScrollMD at none against IV Medications Elsevier's 8. ScrollMD also leads on update cadence (every 3 days vs every 5 months). IV Medications Elsevier's advantage is chart position (#198 vs unranked) and device support (4 vs 1). On price and ads there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. IV Medications Elsevier sells 8 in-app purchases, starting at $25.99 per 3 months. ScrollMD asks for nothing beyond the download.
IV Medications Elsevier ships an update every 5 months, ScrollMD every 3 days. The most recent releases landed on October 13, 2026 and October 10, 2026 respectively.
| Parameter | IV Medications Elsevier | ScrollMD |
|---|---|---|
| Price | Free | Free |
| Rating | 4.6 (71 ratings) — better | — |
| Positive reviews | 33.3% of reviews | — |
| Number of ratings | 71 — better | — |
| Update frequency | Every 5 months | Every 3 days — better |
| Ads | Yes | Yes |
| In-app purchases | Yes | No — better |
| Monetization | Free with in-app purchases | — |
| Best chart rank | #198 — better | — |
| Devices | iPhone, iPad, iPod, Mac — better | iPhone |
| Requires iOS | 13.0 — better | 16.4 |
| Further details — not scored | ||
| Size | 149 MB | 37 MB |
| Age rating | 17+ | 17+ |
| Developer | Skyscape Medpresso Inc | Maytham Al-taan |
In-app purchases
IV Medications Elsevier
- Elsevier’s IV Med HBK 3/M Sub$25.993 Months
- Elsevier’s IV Med HBK 6M Sub$32.996 Months
- 25% Off-Elsevier IVMed 1Y Sub$37.491 Year
Show 4 moreShow fewer
- Elsevier IV Med HBK 1Y Sub off$39.991 Year
- 20% Off-Elsevier IVMed 1Y Sub$39.991 Year
- 15% Off-Elsevier IVMed 1Y Sub$42.491 Year
- Elsevier’s IV Med HBK 1Y Sub1 Month trial$49.991 Year
- Intravenous Medications 2022$49.99
ScrollMD
No in-app purchases
Questions
Is IV Medications Elsevier free?
Is ScrollMD free?
Do IV Medications Elsevier or ScrollMD have ads?
Which is updated more often, IV Medications Elsevier or ScrollMD?
Other comparisons















